Registered entities
Scynexis Inc
Reg. No. 1178253United States
Scynexis, Inc.
Reg. No. 562181648United States
Innovation
42 patent families (26 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport, Emerging technologies; filing pace slowing. Cited 2,180 times.
| Year | Filings |
|---|---|
| 2015 | 11 |
| 2016 | 7 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 3 |
Social engagement
Social engagement: 6.6K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
16 investors on record; lead investors include Alta Partners, SR One, KBL, Societe Generale; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 44% |
| Private equity | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 7 | 44% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
11 Jun 2026 · Director, Drug Product Development · Jersey City
Based on job postings tracked across public sources.
Recent activity
16 Apr 2026
Event
ESCMID 2026